lobbying_activities: 668155

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
668155	60cd6d20-2664-4f79-a1af-fe6eca33c37f	Q3	BROWNSTEIN HYATT FARBER SCHRECK, LLP	7257	JOHNSON & JOHNSON SERVICES, INC.	2008	third_quarter	PHA	Follow-on Biologics Judicial Pay Controlled substances Pre-emption; legal reform S.1695-Biologics Price Competition and Innovation Act of 2007 S.1638-Federal Judicial Salary Restoration Act of 2007 H.R.3753-Federal Judicial Salary Restoration Act of 2007 S.1276-Methamphetamine Production Prevention Act of 2007 S.2274-Dextromethorphan Abuse Reduction Act of 2007 S.2450-To amend the Federal Rules of Evidence to address the waiver of the attorney-client privilege and the work product doctrine	HOUSE OF REPRESENTATIVES,SENATE	90000		0	0	2008-10-15T21:15:30-04:00